My privilege as well to be a part of the amazing #CleClinicCancer breast cancer team. Picture day #2! Still missing some who are busy with patient care.

Thank you for your comments and feedback Wafik S. El-Deiry, MD, PhD, FACP, FRSM !!

It is always exciting to be at the National Comprehensive Cancer Network (NCCN) - #breastcancer Guidelines committee meeting, surrounded by amazingly brilliant people, learn a lot and also have some fun - like retiring of a Jersey 😀 by our team captain William Gradishar, MD

Lorraine is a member of our Lobular Ireland Group. Diagnosed with #ILC when she was just 37, she wants to raise awareness of our Subtype of Breast Cancer which is the 2nd most common #Breastcancer
#LivingWithLobular #NotAlwaysALump
lobularireland.com/2022/10/15/day…

Leaving New York for Cleveland? Here’s How Far Their Money Went. - The New York Times nytimes.com/interactive/20…

If you're confused by the recent #colonoscopy NEJM study, the reason new #ColorectalCancer cases and deaths are ⬇️ in people ages 50+ is...drumroll...colonscopies.

Guardians win! We are cheering on the Cleveland Guardians this playoff season. Thank you for being a founding partner of VeloSano and for your long-time support - go Guards! ❤️⚾️ #VeloSano #StandForTheLand

It was my honor to be sworn in by Secretary Xavier Becerra today as NCI's 16th Director.

Thank you, Dr. Doug Lowy, for being there as well, and for your continued partnership during my first few weeks on the job.

This is an important post neoadjuvant study in high risk Her-2 positive #breastcancer - trastuzumab deruxetecan VS TDM1 NSABP Foundation

Thank you for your advocacy Susan MacDonald Lobular Breast Cancer Alliance

Mitigating acute chemotherapy-associated adverse events in patients with #cancer .

nature.com/articles/s4157…

Dr. Nicole Kuderer 🌎🇺🇸🇪🇺🇺🇦💛💙🌏 Gary Lyman 🇺🇸🇪🇺🇺🇦💛💙 Maryam Lustberg MD MPH Aakash Desai, MD, MPH
#PallOnc #SuppOnc #MedEd

Very excited to hear ⁦Taofeek K Owonikoko⁩ speak (Bruell Memorial lecture) about incredible developments in our understanding of small cell lung cancer, reminds me of the early TCGA days in lung adeno and hope we get similar targets over coming decade! #LCSM ⁦Zack Bruell⁩

Today is #MetastaticBreastCancerAwarenessDay . A recent NCI Minute video summarizes a report on the promising results of an #immunotherapy for some patients with metastatic breast cancer. cancer.gov/news-events/pr… #BreastCancerAwarenessMonth #BCAM

Young Women’s Clinic for Breast Cancer Patients | Cancer Advances Podcast | ⁦Cleveland Clinic⁩ Clinic ⁦Stephanie Valente⁩ ⁦Dale Shepard MD, PhD⁩ my.clevelandclinic.org/podcasts/cance…

Let’s learn about breast cancer and nutrition! 10/19 it’s free. Register here events.clevelandclinic.org/detail-page.ph…

COAST results are quite striking. Is the benefit of combination immune checkpoint therapy stronger in the nonmetastatic setting? It may appear that way at least in NSCLC and MSI+ CRC

Innovative, World Renowned Breast Cancer Experts to Receive Highest Honor from Susan G. Komen® as Recipients ⁦Susan G. Komen⁩ ® - congratulations Dr. Wolmark ⁦NSABP Foundation⁩ ⁦NRG Oncology⁩ ⁦SABCS⁩ #SABCS22 #breastcancer komen.org/news/innovativ…

Finally the 6th edition of our @gulleyj1 book is out amazon.com/Bethesda-Handb… When we started this book during fellowship National Cancer Institute never thought this will become one of the best selling oncology textbooks - with Chinese, Indian, Asian, Spanish editions! Thanks to all the authors !